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Streptococcus pneumoniae (pneumococcus) is a Gram-positive bacterial 
inhabitant of the human respiratory tract, which is pathogenic in certain conditions, thus 
causing high morbidity and mortality. Pneumococcal infections have increased in 
frequency and severity over the past decade because of the emergence of multidrug-
resistant strains. Moreover, the available vaccines are developed against the 
polysaccharide capsule, but their degree of effectiveness is not high, as they do not 
cover most of the 92 serotypes described to date. This makes protein vaccine 
development of great interest since surface proteins antigenically conserved in clinically 
relevant serotypes would be more effective immunogens, and thus might lead to more 
effective vaccines and at lower cost. Proteomics has become a fast and reliable tool for 
vaccine candidate selection. However, in pneumococcus, the high rate of lysis 
occurrence hampers the proteomic analysis of surface protein fractions. In this work, we 
have optimized the conditions for pneumococcal lysis control, and applied a well-
described method for protein vaccine candidate selection in Gram-positive organisms, 
consisting of digestion of living cells followed by LC/MS/MS analysis. This strategy 
allows a quick selection of the most abundant and exposed candidates, which are the 
most promising to raise an immune response. To limit cytoplasmic contamination 
coming from cell lysis, we have cultured the R6 reference strain in different conditions. 
Culturing in a chemically-defined medium (CDM) with ethanolamine was the condition 
in which the greatest number of surface proteins with minor cytoplasmic contamination 
was reached. Then, we analyzed a set of clinical isolates representing those most 
prevalent and invasive in Spain in the last years. Those identified surface proteins 
common to most or all the isolates would be the best candidates for testing their 
protection capacity in animal models. 
